Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med 1979; 300:772.
845 845. Beutler E, Nguyen NJ, Henneberger MW, et al. Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet 1993; 53:85.
846 846. Lewis BD, Nelson PV, Robertson EF, et al. Mutation analysis of 28 Gaucher disease patients: the Australasian experience. Am J Med Genet 1994; 49:218.
847 847. Kerem E, Corey M, Kerem B, et al. The relationship between genotype and phenotype in cystic fibrosis: analysis of the most common mutation. N Engl J Med 1990; 323:1517.
848 848. Cystic Fibrosis Genotype‐Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993; 329:1308.
849 849. Dork T, Wulbrand U, Richter T, et al. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane regulator gene. Hum Genet 1991; 87:441.
850 850. Le C, Ramjeesingh M, Reys E, et al. The cystic fibrosis mutation (F508) does not influence the chloride channel activity of CFTR. Nat Genet 1993; 3:311.
851 851. Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann NY Acad Sci 2010; 1214:57.
852 852. Bradley GM, Blackman SM, Watson CP, et al. Genetic modifiers of nutritional status in cystic fibrosis. Am J Clin Nutr 2012; 96:1299.
853 853. Blackman SM, Commander CW, Watson C. Genetic modifiers of cystic fibrosis‐related diabetes. Diabetes 2013; 62:3627.
854 854. Tuddenham EGD. Factor VIII and haemophilia A. Baillière's Clin Haematol 1989; 2:849.
855 855. McVey JH, Rallapalli PM, Kemball‐Cook G, et al. The European association for haemophilia and allied disorders (EAHAD) coagulation factor variant databases: important resources for haemostasis clinicians and researchers. Haemophilia 2020; 26:306.
856 856. Atik T, Işik E, Onay H, et al. Factor 8 gene mutation spectrum of 270 patients with haemophilia A: identification of 36 novel mutations. Turk J Haematol 2020; 37(3):145.
857 857. Miller DS, Steinbrecher RA, Wieland K, et al. The molecular genetic analysis of haemophilia A: characterization of six partial deletions in the factor VIII gene. Hum Genet 1990; 86:219.
858 858. Sarri CA, Roussaki‐Schulze A, Vasilopoulos Y, et al. Netherton syndrome: a genotype‐phenotype review. Mol Diagn Ther 2017; 21:137.
859 859. Koczkowska M, Callens T, Chen Y, et al. Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p. Met1149, p.Arg1276, and p.Lys1423: genotype‐phenotype study in neurofibromatosis type 1. Hum Mutat 2020; 41:299.
860 860. Lehtonen HJ, Sipponen T, Tojander S, et al. Segregation of a missense variant in entire smooth muscle actin gamma‐2 with autosomal dominant familial visceral myopathy. Gastroenterology 2012; 143:1482.
861 861. Berdon W, Baker D, Blanc W, et al. Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: a new cause of intestinal obstruction in the newborn. Report of radiologic findings in five newborn girls. AJR Am J Roentgenol 1976; 126:957.
862 862. Puri P, Shinkai M. Megacystis‐microcolon‐intestinal‐hypoperistalsis syndrome. Semin Pediatr Surg 2005; 14:58.
863 863. Milunsky M, Baldwin C, Zhang X, et al. Diagnosis of chronic intestinal pseudo‐obstruction & megacystis by sequencing the ACTG2 gene. J Pediatr Gastroenterol Nutr 2017; 65:384.
864 864. Milunsky A, Lazier J, Baldwin C, et al. Prenatal diagnosis of chronic intestinal pseudo‐obstruction and paternal somatic mosaicism for the ACTG2 pathogenic variant. Prenat Diagn 2017; 37:1254.
865 865. Xiromerisiou G, Marogianni C, Dadouli K, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy revisited: genotype‐phenotype correlations of all published cases. Neurol Genet 2020; 6:e434.
866 866. Zhang L, Dong X, Lee M, et al. Single‐cell whole‐genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across human lifespan. Proc Natl Acad Sci U S A 2019; 116:9014.
867 867. Vijg J. Somatic mutations, genome mosaicism, cancer and aging. Curr Opin Genet Dev 2014; 26:141.
868 868. Mirzaa G, Timms AE, Conti V, et al. PIK3CA‐associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight 2016; 1:e.87623.
869 869. Lalonde E, Ebrahimzadeh J, Rafferty K, et al. Molecular diagnosis of somatic overgrowth conditions: a singular‐center experience. Mol Genet Genomic Med 2019; 7:e536.
870 870. Quinlan‐Jones E, Williams D, Bell C, et al. Prenatal detection of PIK3CA‐related overgrowth spectrum in cultured amniocytes using long‐range PCR and next‐generation sequencing. Pediatr Dev Pathol 2017; 20(1):54.
871 871. Tung JY, Lai SHY, Au SLK, et al. Coexistence of paternally‐inherited ABCC8 mutation and mosaic paternal uniparental disomy 11p hyperinsulinism. Int J Pediatr Endocrinol 2020; 2020:13.
872 872. Koh HY, Lee JH. Brain somatic mutations in epileptic disorders. Mol Cells 2018; 41:881.
873 873. Liu AJ, Yang XX, Wu QX, et al. Study on mosaicism of SCN1A gene mutation in parents of children with Dravet syndrome. Zhonghua Er Ke Za Zhi 2017; 55:818.
874 874. Dehainault C, Golmard L, Millot GA, et al. Mosaicism and prenatal diagnosis options: insights from retinoblastoma. Eur J Hum Genet 2017; 25:381.
875 875. D'Gama AM, Walsh CA. Somatic mosaicism and neurodevelopmental disease. Nat Neurosci 2018; 21:1504.
876 876. Rodin RE, Walsh CA. Somatic mutation in pediatric neurological diseases. Pediatr Neurol 2018; 87:20.
877 877. Pham J, Shaw C, Pursley A, et al. Somatic mosaicism detected by exon‐targeted, high resolution aCGH in 10362 consecutive cases. Eur J Hum Genet 2014; 22:969.
878 878. Donnai D, Read AP, McKeown C, et al. Hypomelanosis of Ito‐A manifestation of mosaicism or chimerism. J Med Genet 1988; 25:809.
879 879. Thomas IT, Frias JL, Cantu ES, et al. Association of pigmentary anomalies with chromosomal and genetic mosaicism and chimerism. Am J Hum Genet 1989; 45:193.
880 880. Raghunath M, Mackay K, Dalgleish R, et al. Genetic counseling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation. Eur J Pediatr 1995; 154:123.
881 881. Lund AM, Nicholls AC, Schwartz M, et al. Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV. Acta Paediatr 1997; 86:711.
882 882. Telenius H, Kremer B, Goldberg YP, et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet 1994; 6:409.
883 883. Cancel G, Durr A, Didierjean O, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet 1997; 6:709.
884 884. Satge D, Geneix A, Goburdhun J, et al. A history of miscarriages and mild prognathism as possible mode of presentation of mosaic trisomy 18 in women. Clin Genet 1996; 50:470.
885 885. Comstock JM, Putnam AR, Sangle N, et al. Recurrence of achondrogenesis type 2 in sibs: additional evidence for germline mosaicism. Am J Med Genet A 2010; 152A;1822.
886 886. Abe J, Nakamura K, Nishikomori R, et al. A nationwide survey of Aicardi‐Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study. Rheumatology (Oxford) 2014; 53:448.
887 887. Bruttini M, Vitelli F, Meloni I, et al. Mosaicism in Alport syndrome with genetic counselling. J Med Genet 2000; 37:717.
888 888. Erickson RP. Somatic gene mutation and human disease other than cancer: an update. Mutat Res 2010; 705:96.
889 889. Meira JGC, Sarno MAC, Faria ÁCO, et al. Diagnosis of Atelosteogenesis type I suggested by fetal ultrasonography and atypical paternal phenotype with mosaicism. Rev Bras Ginecol Obstet 2018; 40(9):570.
890 890.